We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
RingCentral
RNG
$6.96B
| $1.59M | ﹤0.01% |
67,200
+22,100
| +49% | +$500K |
2016 Q2
1 quarter
|
|
1852
DELISTED
Atrion Corp
ATRI
| $1.58M | ﹤0.01% |
3,702
-3,176
| -46% | -$1.41M |
2016 Q2
1 quarter
|
|
1853
DELISTED
Nordstrom
JWN
| $1.58M | ﹤0.01% |
30,411
-16,595
| -35% | -$780K |
2016 Q2
1 quarter
|
|
1854
DELISTED
ODP
ODP
| $1.56M | ﹤0.01% |
43,817
-59,926
| -58% | -$2.12M |
2016 Q2
1 quarter
|
|
1855
Vanda Pharmaceuticals
VNDA
$242M
| $1.56M | ﹤0.01% |
93,806
+44,384
| +90% | +$598K |
2016 Q2
1 quarter
|
|
1856
Celestica
CLS
$32.8B
| $1.56M | ﹤0.01% |
144,410
+45,945
| +47% | +$483K |
2016 Q2
1 quarter
|
|
1857
Rigel Pharmaceuticals
RIGL
$899M
| $1.55M | ﹤0.01% |
42,339
+16,843
| +66% | +$483K |
2016 Q2
1 quarter
|
|
1858
Destination XL Group
DXLG
$27.2M
| $1.55M | ﹤0.01% |
358,365
-162,803
| -31% | -$794K |
2016 Q2
1 quarter
|
|
1859
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $1.55M | ﹤0.01% |
+132,100
| New | +$1.54M |
2016 Q3
0 quarters
|
|
1860
DELISTED
First of Long Island Corp
FLIC
| $1.55M | ﹤0.01% |
70,197
+9,447
| +16% | +$197K |
2016 Q2
1 quarter
|
|
1861
Scansource
SCSC
$1.23B
| $1.55M | ﹤0.01% |
42,519
-4,075
| -9% | -$159K |
2016 Q2
1 quarter
|
|
1862
Idacorp
IDA
$8.14B
| $1.55M | ﹤0.01% |
19,806
-54,382
| -73% | -$4.29M |
2016 Q2
1 quarter
|
|
1863
DELISTED
NextEra Energy, Inc.
NEE.PRQ
| $1.55M | ﹤0.01% |
26,253
-35,549
| -58% | -$2.18M |
2016 Q2
1 quarter
|
|
|
ITC
1864
DELISTED
ITC HOLDINGS CORP
ITC
| $1.55M | ﹤0.01% |
33,331
-4,252
| -11% | -$197K |
2016 Q2
1 quarter
|
|
1865
EXL Service
EXLS
$6.41B
| $1.55M | ﹤0.01% |
155,220
-49,200
| -24% | -$500K |
2016 Q2
1 quarter
|
|
1866
Minerals Technologies
MTX
$1.96B
| $1.55M | ﹤0.01% |
21,885
-21,885
| -50% | -$1.46M |
2016 Q2
1 quarter
|
|
|
NSTG
1867
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.55M | ﹤0.01% |
77,403
+28,739
| +59% | +$456K |
2016 Q2
1 quarter
|
|
1868
Sanofi
SNY
$100B
| $1.54M | ﹤0.01% |
40,450
-45,503
| -53% | -$1.83M |
2016 Q2
1 quarter
|
|
1869
DELISTED
Dermira, Inc.
DERM
| $1.54M | ﹤0.01% |
45,602
+10,470
| +30% | +$337K |
2016 Q2
1 quarter
|
|
|
LTRPA
1870
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.54M | ﹤0.01% |
70,433
+50,345
| +251% | +$1.1M |
2016 Q2
1 quarter
|
|
1871
DELISTED
Theravance Biopharma
TBPH
| $1.53M | ﹤0.01% |
42,317
-3,807
| -8% | -$106K |
2016 Q2
1 quarter
|
|
1872
DELISTED
US Steel
X
| $1.53M | ﹤0.01% |
81,199
-19,445
| -19% | -$401K |
2016 Q2
1 quarter
|
|
1873
Hyatt Hotels
H
$16.3B
| $1.53M | ﹤0.01% |
31,099
-24,373
| -44% | -$1.26M |
2016 Q2
1 quarter
|
|
1874
DELISTED
Meridian Bioscience Inc
VIVO
| $1.53M | ﹤0.01% |
79,202
-119,284
| -60% | -$2.33M |
2016 Q2
1 quarter
|
|
1875
Alto Ingredients
ALTO
$280M
| $1.52M | ﹤0.01% |
220,780
-449,813
| -67% | -$2.9M |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.